Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NFκB to promote axonal regeneration and remyelination.
Anjali YadavTzu-Chieh HuangSzu-Han ChenThamil Selvee RamasamyYuan-Yu HsuehShau-Ping LinFu-I LuYa-Hsin LiuChia-Ching WuPublished in: Journal of neuroinflammation (2021)
Suppressing the lengthened state of inflammation using PBA treatment favors axonal regrowth and remyelination following nerve transection injury. PBA treatment also regulates pro-inflammatory cytokine expression by inhibiting the transcriptional activation of NFκB-p65 and HDAC3 in SCs in vitro.